The goal of the Cancer Epidemiology Program is to study environmental, genetic, and molecular risks for cancer and cancer outcomes with an emphasis on disparities. Because we are a public comprehensive cancer center and because North Carolina in many ways mimics the American population, the Program addresses these important questions through multidimensional North Carolina population-based and hospital-based studies. Notable translational cross-program research and high impact publications have been obtained in an inter-disciplinary manner with members of the cancer control and prevention, clinical, genetics, breast, cancer, cell biology and other programs. Program members conduct research with great impact, including population- based studies in breast, colon, prostate, and head and neck cancer, throughout our catchment area (the state of North Carolina) and at UNC Hospital; and the program is focused on cancer health disparities, especially black-white differences. This innovative research model successfully integrates classic risk factor epidemiology, molecular and genetic epidemiology, tumor biology, clinical factors, and prospective follow-up for outcomes. For example, the Program?s Carolina Breast Cancer Study has reshaped our understanding of disparities in breast cancer risk factors, tumor biology, and mortality among African-American women. New and novel North Carolina-based studies in bladder, head and neck, and kidney cancer are planned. Program members collaborate in national and international consortia and with other cancer centers. The Program brings value to the Center through population- and hospital based studies that include systematic collection of exposure, outcome data, and biospecimens, a unique shared resource (Rapid Case Ascertainment), and its expertise in epidemiologic methods development and application. The Program effectively obtains value from the center through UNC Lineberger?s strong support for faculty recruitments, extensive support for important shared resources and developmental funds, which members leverage. The UNC Lineberger strategic plan emphasis on optimizing cancer outcomes in North Carolina led to significant investment across the population sciences including significant faculty recruiting. CE recruited 11 new program members both nationally- recognized senior investigators and promising junior faculty. There are 23 members from 7 different departments in the Schools of Public Health and Medicine and the College of Arts and Sciences. During the last funding period, program members have published 629 cancer- related articles (38% collaborative). In 2014, our program members held 53 grants and $13M (total cost) in annual extramural funding, including 25 grants and $6.6M (total costs) from the NCI.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Chapel Hill
United States
Zip Code
Shao, Wenwei; Chen, Xiaojing; Samulski, Richard J et al. (2018) Inhibition of antigen presentation during AAV gene therapy using virus peptides. Hum Mol Genet 27:601-613
Gao, Yanzhe; Kardos, Jordan; Yang, Yang et al. (2018) The Cancer/Testes (CT) Antigen HORMAD1 promotes Homologous Recombinational DNA Repair and Radioresistance in Lung adenocarcinoma cells. Sci Rep 8:15304
Schaefer, Kristina N; Bonello, Teresa T; Zhang, Shiping et al. (2018) Supramolecular assembly of the beta-catenin destruction complex and the effect of Wnt signaling on its localization, molecular size, and activity in vivo. PLoS Genet 14:e1007339
Zuze, Takondwa; Painschab, Matthew S; Seguin, Ryan et al. (2018) Plasmablastic lymphoma in Malawi. Infect Agent Cancer 13:22
Wang, Jeremy R; Holt, James; McMillan, Leonard et al. (2018) FMLRC: Hybrid long read error correction using an FM-index. BMC Bioinformatics 19:50
Lee, Janie M; Abraham, Linn; Lam, Diana L et al. (2018) Cumulative Risk Distribution for Interval Invasive Second Breast Cancers After Negative Surveillance Mammography. J Clin Oncol 36:2070-2077
Shen, Hui; Shih, Juliann; Hollern, Daniel P et al. (2018) Integrated Molecular Characterization of Testicular Germ Cell Tumors. Cell Rep 23:3392-3406
Cousins, Emily M; Goldfarb, Dennis; Yan, Feng et al. (2018) Competitive Kinase Enrichment Proteomics Reveals that Abemaciclib Inhibits GSK3? and Activates WNT Signaling. Mol Cancer Res 16:333-344
Armstrong, Robin L; Penke, Taylor J R; Strahl, Brian D et al. (2018) Chromatin conformation and transcriptional activity are permissive regulators of DNA replication initiation in Drosophila. Genome Res 28:1688-1700
Hoadley, Katherine A; Yau, Christina; Hinoue, Toshinori et al. (2018) Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. Cell 173:291-304.e6

Showing the most recent 10 out of 1525 publications